Biomarkers usage in minimally invasive diagnosis of nonalcoholic steatohepatitis in nonalcoholic fatty liver disease patients
dc.contributor.author | Babak, Oleg | |
dc.contributor.author | Molodan, Volodymyr | |
dc.contributor.author | Lapshyna, Kateryna | |
dc.contributor.author | Prosolenko, Kostyantyn | |
dc.date.accessioned | 2017-12-04T07:09:31Z | |
dc.date.available | 2017-12-04T07:09:31Z | |
dc.date.issued | 2017 | |
dc.description.abstract | Plasma CK-18 and FGF-21 levels are increased in patients with NASH and also associate with atherogenic dyslipidemia and impaired liver enzyme activity. Study plasma levels of CK-18 and FGF21 allows to establish the presence of NASH in patients with NAFLD. The findings suggest the possibility of using these biomarkers for minimally invasive screening diagnosis of NASH and represent the perspective of further research. | ru_RU |
dc.identifier.citation | Biomarkers usage in minimally invasive diagnosis of nonalcoholic steatohepatitis in nonalcoholic fatty liver disease patients /O. Y. Babak, V. I. Molodan, K. A. Lapshyna, K. O. Prosolenko // The New Armenian Medical Journal. – 2017. – Т. 11, № 2. – P. 46–51. | ru_RU |
dc.identifier.uri | https://repo.knmu.edu.ua/handle/123456789/18470 | |
dc.language.iso | en_US | ru_RU |
dc.subject | NAFLD | ru_RU |
dc.subject | hypertension | ru_RU |
dc.title | Biomarkers usage in minimally invasive diagnosis of nonalcoholic steatohepatitis in nonalcoholic fatty liver disease patients | ru_RU |
dc.type | Article | ru_RU |